Filament Health, recently became the first psychedelic drug discovery and development company to receive FDA approval to conduct a natural psychedelic clinical trial, which they're presently performing in partnership with the University of California, San Francisco. In this episode,  Adam Torres interviewed Benjamin Lightburn, CEO of Filament Health. Explore the current state of mental health and how companies like Filament Health are working towards solutions

Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.

Apply to be a guest on our podcast:
https://missionmatters.lpages.co/podcastguest/

Visit our website:
https://missionmatters.com/

More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Learn more about your ad choices. Visit podcastchoices.com/adchoices